(Q45880556)

17 December 2017

title

A nanomedicine to treat ocular surface inflammation: performance on an experimental dry eye murine model (English)

1 reference

17 December 2017

0 references

0 references

1 reference

5

1 reference

17 December 2017

Yolanda Diebold

8

1 reference

17 December 2017

author name string

L Contreras-Ruiz

1

1 reference

17 December 2017

G K Zorzi

2

1 reference

17 December 2017

D Hileeto

3

1 reference

17 December 2017

A López-García

4

1 reference

17 December 2017

B Seijo

6

1 reference

17 December 2017

A Sánchez

7

1 reference

17 December 2017

publication date

19 July 2012

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

20

1 reference

17 December 2017

issue

5

1 reference

17 December 2017

page(s)

467-477

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/gt.2012.56

exact match

0 references

cites work

Ocular mucin gene expression levels as biomarkers for the diagnosis of dry eye syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

The ocular surface: the challenge to enable and protect vision: the Friedenwald lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

Effect of gene therapy on visual function in Leber's congenital amaurosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

Chitosan-based nanostructures: a delivery platform for ocular therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

Chitosan nanoparticles for drug delivery to the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

Applications of nanoparticles in ophthalmology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

Nanoparticle applications in ocular gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

Expression of MUC5AC in ocular surface epithelial cells using cationized gelatin nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

Cationic vectors in ocular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

Bioadhesive hyaluronan-chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

Corneal epithelium as a platform for secretion of transgene products after transfection with liposomal gene eyedrops

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

Hybrid nanoparticle design based on cationized gelatin and the polyanions dextran sulfate and chondroitin sulfate for ocular gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

Tear film and ocular surface tests in animal models of dry eye: uses and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

Goblet cell density in ocular surface disease. A better indicator than tear mucin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

Rat Muc4 (sialomucin complex) reduces binding of anti-ErbB2 antibodies to tumor cell surfaces, a potential mechanism for herceptin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

Chemically Modified Gelatin as Biomaterial in the Design of New Nanomedicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

21 January 2018

Inflammation in dry eye.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

7 January 2021

The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

7 January 2021

Structural and functional alteration of corneal epithelial barrier under inflammatory conditions

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

7 January 2021

Conjunctival goblet cell densities in ocular surface disease

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

7 January 2021

Desiccating Stress Induces T Cell-Mediated Sjogren's Syndrome-Like Lacrimal Keratoconjunctivitis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.56

7 January 2021

Identifiers

DOI

10.1038/GT.2012.56

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017